| Dr Jeffrey Spencer Chen, MD, PHD | |
|
2500 Ne Neff Rd, Bend, OR 97701-6015 | |
| (541) 706-5811 | |
| (541) 706-5867 |
| Full Name | Dr Jeffrey Spencer Chen |
|---|---|
| Gender | Male |
| Speciality | Hospitalist |
| Experience | 26 Years |
| Location | 2500 Ne Neff Rd, Bend, Oregon |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1578880845 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208M00000X | Hospitalist | MD163508 (Oregon) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Charles Medical Center - Bend | Bend, OR | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| St Charles Health System Inc | 3870402852 | 150 |
News Archive
S1 Biopharma is a developer of first-in-class drugs for sexual dysfunction in both women and men. The company's lead compound, Lorexys, is currently in Phase IIb for the treatment of hypoactive sexual desire disorder (HSDD).
Researchers have shown that The Liverpool Lung Project Risk Model is effective in identifying those at the highest risk for lung cancer within 5 years, and who are therefore suitable for computed tomography screening.
Cancer Research UK and the Cancer Research Technology Pioneer Fund have committed £2.5 million in collaboration with the National Cancer Institute in the US to tackle one of the toughest challenges in cancer that has thwarted researchers for more than 30 years.
According to a new study published this week in the journal Pediatrics, quite a few breast feeding women are not abstaining from alcohol and are thus causing exposure of their babies to alcohol. They write in their study that children who are exposed to alcohol in the breast milk that they take are likely to have lower cognitive abilities.
› Verified 9 days ago
| Entity Name | St Charles Health System Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1982621447 PECOS PAC ID: 3870402852 Enrollment ID: O20040112000045 |
News Archive
S1 Biopharma is a developer of first-in-class drugs for sexual dysfunction in both women and men. The company's lead compound, Lorexys, is currently in Phase IIb for the treatment of hypoactive sexual desire disorder (HSDD).
Researchers have shown that The Liverpool Lung Project Risk Model is effective in identifying those at the highest risk for lung cancer within 5 years, and who are therefore suitable for computed tomography screening.
Cancer Research UK and the Cancer Research Technology Pioneer Fund have committed £2.5 million in collaboration with the National Cancer Institute in the US to tackle one of the toughest challenges in cancer that has thwarted researchers for more than 30 years.
According to a new study published this week in the journal Pediatrics, quite a few breast feeding women are not abstaining from alcohol and are thus causing exposure of their babies to alcohol. They write in their study that children who are exposed to alcohol in the breast milk that they take are likely to have lower cognitive abilities.
› Verified 9 days ago
| Entity Name | Salem Health West Valley |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1245237486 PECOS PAC ID: 7810804630 Enrollment ID: O20040225000830 |
News Archive
S1 Biopharma is a developer of first-in-class drugs for sexual dysfunction in both women and men. The company's lead compound, Lorexys, is currently in Phase IIb for the treatment of hypoactive sexual desire disorder (HSDD).
Researchers have shown that The Liverpool Lung Project Risk Model is effective in identifying those at the highest risk for lung cancer within 5 years, and who are therefore suitable for computed tomography screening.
Cancer Research UK and the Cancer Research Technology Pioneer Fund have committed £2.5 million in collaboration with the National Cancer Institute in the US to tackle one of the toughest challenges in cancer that has thwarted researchers for more than 30 years.
According to a new study published this week in the journal Pediatrics, quite a few breast feeding women are not abstaining from alcohol and are thus causing exposure of their babies to alcohol. They write in their study that children who are exposed to alcohol in the breast milk that they take are likely to have lower cognitive abilities.
› Verified 9 days ago
| Entity Name | Salem Health |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1265431829 PECOS PAC ID: 8628986668 Enrollment ID: O20040309001131 |
News Archive
S1 Biopharma is a developer of first-in-class drugs for sexual dysfunction in both women and men. The company's lead compound, Lorexys, is currently in Phase IIb for the treatment of hypoactive sexual desire disorder (HSDD).
Researchers have shown that The Liverpool Lung Project Risk Model is effective in identifying those at the highest risk for lung cancer within 5 years, and who are therefore suitable for computed tomography screening.
Cancer Research UK and the Cancer Research Technology Pioneer Fund have committed £2.5 million in collaboration with the National Cancer Institute in the US to tackle one of the toughest challenges in cancer that has thwarted researchers for more than 30 years.
According to a new study published this week in the journal Pediatrics, quite a few breast feeding women are not abstaining from alcohol and are thus causing exposure of their babies to alcohol. They write in their study that children who are exposed to alcohol in the breast milk that they take are likely to have lower cognitive abilities.
› Verified 9 days ago
| Entity Name | Salem Health Professional Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1285774257 PECOS PAC ID: 5294094769 Enrollment ID: O20180109003027 |
News Archive
S1 Biopharma is a developer of first-in-class drugs for sexual dysfunction in both women and men. The company's lead compound, Lorexys, is currently in Phase IIb for the treatment of hypoactive sexual desire disorder (HSDD).
Researchers have shown that The Liverpool Lung Project Risk Model is effective in identifying those at the highest risk for lung cancer within 5 years, and who are therefore suitable for computed tomography screening.
Cancer Research UK and the Cancer Research Technology Pioneer Fund have committed £2.5 million in collaboration with the National Cancer Institute in the US to tackle one of the toughest challenges in cancer that has thwarted researchers for more than 30 years.
According to a new study published this week in the journal Pediatrics, quite a few breast feeding women are not abstaining from alcohol and are thus causing exposure of their babies to alcohol. They write in their study that children who are exposed to alcohol in the breast milk that they take are likely to have lower cognitive abilities.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jeffrey Spencer Chen, MD, PHD Po Box 13129, Salem, OR 97309-1129 Ph: () - | Dr Jeffrey Spencer Chen, MD, PHD 2500 Ne Neff Rd, Bend, OR 97701-6015 Ph: (541) 706-5811 |
News Archive
S1 Biopharma is a developer of first-in-class drugs for sexual dysfunction in both women and men. The company's lead compound, Lorexys, is currently in Phase IIb for the treatment of hypoactive sexual desire disorder (HSDD).
Researchers have shown that The Liverpool Lung Project Risk Model is effective in identifying those at the highest risk for lung cancer within 5 years, and who are therefore suitable for computed tomography screening.
Cancer Research UK and the Cancer Research Technology Pioneer Fund have committed £2.5 million in collaboration with the National Cancer Institute in the US to tackle one of the toughest challenges in cancer that has thwarted researchers for more than 30 years.
According to a new study published this week in the journal Pediatrics, quite a few breast feeding women are not abstaining from alcohol and are thus causing exposure of their babies to alcohol. They write in their study that children who are exposed to alcohol in the breast milk that they take are likely to have lower cognitive abilities.
› Verified 9 days ago
Kevin Ducey, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 2500 Ne Neff Rd, Bend, OR 97701 Phone: 503-494-8211 | |
Lori Ann Beireis, D.O. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 2500 Ne Neff Rd, Bend, OR 97701 Phone: 541-706-6892 Fax: 541-706-6813 | |
Dr. David Eric Barnett, D.O. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 2500 Ne Neff Rd, Bend, OR 97701 Phone: 541-382-4321 | |
Dr. Victor A Nwanguma, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1501 Ne Medical Center Dr, Bend, OR 97701 Phone: 541-706-6532 | |
Ann Elisabeth Kellogg, D.O. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 2500 Ne Neff Rd, Bend, OR 97701 Phone: 541-382-4321 | |
Jennifer R Ashley, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 2500 Ne Neff Rd, Bend, OR 97701 Phone: 541-706-5811 Fax: 541-706-5867 |